Skip to main content
. Author manuscript; available in PMC: 2009 Dec 8.
Published in final edited form as: Am J Med. 2004 Dec 1;117(11):811–822. doi: 10.1016/j.amjmed.2004.06.034

Table 3.

Treatment Eligibility Rates

Entire Cohort Northeast South Midwest West P for Interaction
Percentage
Aspirin on admission 0.002
 Overall 85.4 85.9 84.9 84.7 86.5
 White 85.3 85.9 84.7 84.8 86.6
 Black 85.6 84.5 86.6 83.7 85.4
P value 0.54 0.12 <0.001 0.21 0.39
Beta-blockers on admission 0.47
 Overall 42.1 39.7 42.6 43.2 43.5
 White 42.3 39.8 42.9 43.4 43.7
 Black 39.5 38.6 39.7 39.5 39.6
P value <0.001 0.38 <0.001 0.001 0.03
Aspirin at discharge 0.08
 Overall 34.7 36.3 32.8 32.1 40.6
 White 34.4 36.2 32.2 31.8 40.5
 Black 38.8 39.8 38.5 35.9 45.4
P value <0.001 0.005 <0.001 <0.001 0.01
Beta-blockers at discharge 0.75
 Overall 18.8 17.0 18.6 19.0 22.2
 White 18.8 17.0 18.4 19.0 22.2
 Black 19.8 17.1 19.7 20.5 23.9
P value 0.02 0.96 0.02 0.11 0.28